Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that researchers at NYU Grossman School of Medicine, led by Sripal Bangalore, MD, interventional cardiologist and professor of Medicine, are initiating an Investigator-Sponsored Trial, known as BARCONA, to study the effect of bardoxolone methyl in patients suffering from COVID-19.
July 28, 2020
· 3 min read